14 insiders reported 328 Form 4 transactions for Roivant Sciences Ltd. (ROIV) over the past 18 months (most recent 2026-09-22). Recent activity: Pulik Richard (CFO) Sell 2,129 shares, Humes Jennifer (Chief Accounting Officer) Sell 3,880 shares, MOMTAZEE JAMES C (Director) Buy 5,054 shares, MANCHESTER KEITH S (Director) Buy 5,054 shares, Fitzgerald Meghan (Director) Buy 5,054 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Pulik Richard | CFO | Sell | 2,129 | $84,670 |
| 2026-09-22 | Humes Jennifer | Chief Accounting Officer | Sell | 3,880 | $154,308 |
| 2026-09-18 | MOMTAZEE JAMES C | Director | Buy | 5,054 | $0 |
| 2026-09-18 | MANCHESTER KEITH S | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Fitzgerald Meghan | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Oren Ilan | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Epperly Melissa B, | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Gold Daniel Allen | Director | Buy | 5,054 | $0 |
| 2026-09-17 | Epperly Melissa B, | Director | Sell | 4,338 | $172,002 |
| 2026-09-17 | Fitzgerald Meghan | Director | Sell | 4,712 | $186,972 |
| 2026-09-17 | Fitzgerald Meghan | Director | Sell | 400 | $16,180 |
| 2026-09-17 | Epperly Melissa B, | Director | Sell | 600 | $24,228 |
| 2026-09-14 | Fitzgerald Meghan | Director | Sell | 1,743 | $71,358 |
| 2026-09-14 | Oren Ilan | Director | Sell | 2,378 | $97,355 |
| 2026-09-14 | Epperly Melissa B, | Director | Sell | 2,179 | $89,208 |
| 2026-09-14 | Gold Daniel Allen | Director | Sell | 5,133 | $210,145 |
| 2026-09-14 | MOMTAZEE JAMES C | Director | Sell | 2,905 | $118,931 |
| 2026-09-10 | Fitzgerald Meghan | Director | Buy | 20,000 | $176,000 |
| 2026-09-10 | Fitzgerald Meghan | Director | Sell | 20,000 | $798,000 |
| 2026-09-01 | Venker Eric | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-09-01 | Venker Eric | President & Immunovant CEO | Sell | 166,182 | $5.9M |
| 2026-09-01 | Venker Eric | President & Immunovant CEO | Sell | 33,818 | $1.2M |
| 2026-08-24 | Venker Eric | President & Immunovant CEO | Sell | 13,909 | $512,408 |
| 2026-08-24 | Pulik Richard | CFO | Sell | 5,749 | $211,793 |
| 2026-08-21 | Sukhatme Mayukh | President & CIO | Buy | 172,899 | $665,661 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22